Mesenchymal stem cells and neuroregeneration in Parkinson's disease

Experimental Neurology

Volumn 247, Issue , 2013, Pages 25-38

  Glavaski Joksimovic, Aleksandra ^a   Bohn, Martha C ^b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Dopaminergic neurons; Mesenchymal stem cells; Neuroprotection; Neuroregeneration; Parkinson's disease

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; NERVE GROWTH FACTOR RECEPTOR;

BIOLOGICAL ACTIVITY; CELL FUSION; CELL INTERACTION; CELL REGENERATION; CELL TRANSDIFFERENTIATION; CONVALESCENCE; CYTOARCHITECTURE; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; EXPERIMENTAL MODEL; HOST CELL; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PARACRINE SIGNALING; PARKINSON DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THERAPY EFFECT;

DOPAMINERGIC NEURONS; MESENCHYMAL STEM CELLS; NEUROPROTECTION; NEUROREGENERATION; PARKINSON'S DISEASE;

ANIMALS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NERVE DEGENERATION; PARKINSON DISEASE;

EID: 84876743127     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.03.016     Document Type: Review

References (299)

1. Aizman I., Tate C.C., McGrogan M., Case C.C. Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth. J. Neurosci. Res. 2009, 87:3198-3206.
2. Alexanian A.R. Neural stem cells induce bone-marrow-derived mesenchymal stem cells to generate neural stem-like cells via juxtacrine and paracrine interactions. Exp. Cell Res. 2005, 310:383-391.
3. Alexanian A.R., Maiman D.J., Kurpad S.N., Gennarelli T.A. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev. 2008, 17:1123-1130.
4. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425:968-973.
5. Amariglio N., Hirshberg A., Scheithauer B.W., Cohen Y., Loewenthal R., Trakhtenbrot L., Paz N., Koren-Michowitz M., Waldman D., Leider-Trejo L., Toren A., Constantini S., Rechavi G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009, 6:e1000029.
6. Anghileri E., Marconi S., Pignatelli A., Cifelli P., Galie M., Sbarbati A., Krampera M., Belluzzi O., Bonetti B. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev. 2008, 17:909-916.
7. Arnhold S., Klein H., Klinz F.J., Absenger Y., Schmidt A., Schinkothe T., Brixius K., Kozlowski J., Desai B., Bloch W., Addicks K. Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. Eur. J. Cell Biol. 2006, 85:551-565.
8. Asada H., Ip N.Y., Pan L., Razack N., Parfitt M.M., Plunkett R.J. Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum. J. Neurosci. Res. 1995, 40:22-30.
9. Aubin N., Curet O., Deffois A., Carter C. Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J. Neurochem. 1998, 71:1635-1642.
10. Bahat-Stroomza M., Barhum Y., Levy Y.S., Karpov O., Bulvik S., Melamed E., Offen D. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J. Mol. Neurosci. 2009, 39:199-210.
11. Bai L., Caplan A., Lennon D., Miller R.H. Human mesenchymal stem cells signals regulate neural stem cell fate. Neurochem. Res. 2007, 32:353-362.
12. Bankiewicz K.S., Plunkett R.J., Jacobowitz D.M., Porrino L., di Porzio U., London W.T., Kopin I.J., Oldfield E.H. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J. Neurosurg. 1990, 72:231-244.
13. Bankiewicz K.S., Plunkett R.J., Jacobowitz D.M., Kopin I.J., Oldfield E.H. Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies. J. Neurosurg. 1991, 74:97-104.
14. Bankiewicz K.S., Palmatier M., Plunkett R.J., Cummins A., Oldfield E.H. Reversal of hemiparkinsonian syndrome in nonhuman primates by amnion implantation into caudate nucleus. J. Neurosurg. 1994, 81:869-876.
15. Bao X., Wei J., Feng M., Lu S., Li G., Dou W., Ma W., Ma S., An Y., Qin C., Zhao R.C., Wang R. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 2011, 1367:103-113.
16. Bartosh T.J., Ylostalo J.H., Mohammadipoor A., Bazhanov N., Coble K., Claypool K., Lee R.H., Choi H., Prockop D.J. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13724-13729.
17. Barzilay R., Kan I., Ben-Zur T., Bulvik S., Melamed E., Offen D. Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev. 2008, 17:547-554.
18. Barzilay R., Ben-Zur T., Bulvik S., Melamed E., Offen D. Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev. 2009, 18:591-602.
19. Batchelor P.E., Liberatore G.T., Wong J.Y., Porritt M.J., Frerichs F., Donnan G.A., Howells D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 1999, 19:1708-1716.
20. Bertani N., Malatesta P., Volpi G., Sonego P., Perris R. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. J. Cell Sci. 2005, 118:3925-3936.
21. Bjorklund A., Rosenblad C., Winkler C., Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 1997, 4:186-200.
22. Bjorklund A., Kirik D., Rosenblad C., Georgievska B., Lundberg C., Mandel R.J. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res. 2000, 886:82-98.
23. Bjorklund L.M., Sanchez-Pernaute R., Chung S., Andersson T., Chen I.Y., McNaught K.S., Brownell A.L., Jenkins B.G., Wahlestedt C., Kim K.S., Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:2344-2349.
24. Blandini F., Cova L., Armentero M.T., Zennaro E., Levandis G., Bossolasco P., Calzarossa C., Mellone M., Giuseppe B., Deliliers G.L., Polli E., Nappi G., Silani V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 2010, 19:203-217.
25. Blondheim N.R., Levy Y.S., Ben-Zur T., Burshtein A., Cherlow T., Kan I., Barzilai R., Bahat-Stromza M., Barhum Y., Bulvik S., Melamed E., Offen D. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev. 2006, 15:141-164.
26. Bohn M.C. Parkinson's disease: a neurodegenerative disease particularly amenable to gene therapy. Mol. Ther. 2000, 1:494-496.
27. Bohn M.C., Cupit L., Marciano F., Gash D.M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 1987, 237:913-916.
28. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 1994, 172:151-154.
29. Bouchez G., Sensebe L., Vourc'h P., Garreau L., Bodard S., Rico A., Guilloteau D., Charbord P., Besnard J.C., Chalon S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem. Int. 2008, 52:1332-1342.
30. Brazelton T.R., Rossi F.M., Keshet G.I., Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000, 290:1775-1779.
31. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., Morizane A., Bergquist F., Riebe I., Nannmark U., Carta M., Hanse E., Takahashi J., Sasai Y., Funa K., Brundin P., Eriksson P.S., Li J.Y. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006, 24:1433-1440.
32. Burdon T.J., Paul A., Noiseux N., Prakash S., Shum-Tim D. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res. 2011, 2011:207326.
33. Cai J., Yang M., Poremsky E., Kidd S., Schneider J.S., Iacovitti L. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev. 2010, 19:1017-1023.
34. Caiazzo M., Dell'Anno M.T., Dvoretskova E., Lazarevic D., Taverna S., Leo D., Sotnikova T.D., Menegon A., Roncaglia P., Colciago G., Russo G., Carninci P., Pezzoli G., Gainetdinov R.R., Gustincich S., Dityatev A., Broccoli V. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476:224-227.
35. Camp D.M., Loeffler D.A., Farrah D.M., Borneman J.N., LeWitt P.A. Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease. J. Neuroinflammation 2009, 6:17.
36. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
37. Castano A., Herrera A.J., Cano J., Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem. 2002, 81:150-157.
38. Chadi G., Moller A., Rosen L., Janson A.M., Agnati L.A., Goldstein M., Ogren S.O., Pettersson R.F., Fuxe K. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp. Brain Res. 1993, 97:145-158.
39. Chan C.S., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., Meredith G.E., Surmeier D.J. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 2007, 447:1081-1086.
40. Chang Y.L., Chen S.J., Kao C.L., Hung S.C., Ding D.C., Yu C.C., Chen Y.J., Ku H.H., Lin C.P., Lee K.H., Chen Y.C., Wang J.J., Hsu C.C., Chen L.K., Li H.Y., Chiou S.H. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology. Cell Transplant. 2012, 21:313-332.
41. Chao Y.X., He B.P., Tay S.S. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J. Neuroimmunol. 2009, 216:39-50.
42. Chen J., Li Y., Wang L., Lu M., Zhang X., Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 2001, 189:49-57.
43. Chen X., Katakowski M., Li Y., Lu D., Wang L., Zhang L., Chen J., Xu Y., Gautam S., Mahmood A., Chopp M. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J. Neurosci. Res. 2002, 69:687-691.
44. Chen H., Zhang S.M., Hernan M.A., Schwarzschild M.A., Willett W.C., Colditz G.A., Speizer F.E., Ascherio A. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch. Neurol. 2003, 60:1059-1064.
45. Chen L.W., Zhang J.P., Kwok-Yan Shum D., Chan Y.S. Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice. J. Comp. Neurol. 2006, 497:898-909.
46. Cho K.J., Trzaska K.A., Greco S.J., McArdle J., Wang F.S., Ye J.H., Rameshwar P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 2005, 23:383-391.
47. Choi-Lundberg D.L., Lin Q., Chang Y.N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 1997, 275:838-841.
48. Choi-Lundberg D.L., Lin Q., Schallert T., Crippens D., Davidson B.L., Chang Y.N., Chiang Y.L., Qian J., Bardwaj L., Bohn M.C. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 1998, 154:261-275.
49. Choong P.F., Mok P.L., Cheong S.K., Leong C.F., Then K.Y. Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy 2007, 9:170-183.
50. Chu Q., Wang Y., Fu X., Zhang S. Mechanism of in vitro differentiation of bone marrow stromal cells into neuron-like cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2004, 24:259-261.
51. Chu M.S., Chang C.F., Yang C.C., Bau Y.C., Ho L.L., Hung S.C. Signalling pathway in the induction of neurite outgrowth in human mesenchymal stem cells. Cell. Signal. 2006, 18:519-530.
52. Cicchetti F., Brownell A.L., Williams K., Chen Y.I., Livni E., Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 2002, 15:991-998.
53. Colletti E.J., Airey J.A., Liu W., Simmons P.J., Zanjani E.D., Porada C.D., Almeida-Porada G. Generation of tissue-specific cells from MSC does not require fusion or donor-to-host mitochondrial/membrane transfer. Stem Cell Res. 2009, 2:125-138.
54. Connor B., Kozlowski D.A., Schallert T., Tillerson J.L., Davidson B.L., Bohn M.C. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged parkinsonian rat. Gene Ther. 1999, 6:1936-1951.
55. Cooper O., Hargus G., Deleidi M., Blak A., Osborn T., Marlow E., Lee K., Levy A., Perez-Torres E., Yow A., Isacson O. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci. 2010, 45:258-266.
56. Coquery N., Blesch A., Stroh A., Fernandez-Klett F., Klein J., Winter C., Priller J. Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity. Cytotherapy 2012, 14:1041-1053.
57. Cova L., Armentero M.T., Zennaro E., Calzarossa C., Bossolasco P., Busca G., Lambertenghi Deliliers G., Polli E., Nappi G., Silani V., Blandini F. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res. 2010, 1311:12-27.
58. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 2006, 198:54-64.
59. Croitoru-Lamoury J., Lamoury F.M., Zaunders J.J., Veas L.A., Brew B.J. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J. Interferon Cytokine Res. 2007, 27:53-64.
60. Cunningham L.A., Short M.P., Vielkind U., Breakefield X.O., Bohn M.C. Survival and differentiation within the adult mouse striatum of grafted rat pheochromocytoma cells (PC12) genetically modified to express recombinant beta-NGF. Exp. Neurol. 1991, 112:174-182.
61. Danielyan L., Schafer R., von Ameln-Mayerhofer A., Bernhard F., Verleysdonk S., Buadze M., Lourhmati A., Klopfer T., Schaumann F., Schmid B., Koehle C., Proksch B., Weissert R., Reichardt H.M., van den Brandt J., Buniatian G.H., Schwab M., Gleiter C.H., Frey W.H. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res. 2011, 14:3-16.
62. Date I., Ohmoto T., Imaoka T., Ono T., Hammang J.P., Francis J., Greco C., Emerich D.F. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J. Neurosurg. 1996, 84:1006-1012.
63. Date I., Shingo T., Ohmoto T., Emerich D.F. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells. Exp. Neurol. 1997, 147:10-17.
64. Datta I., Mishra S., Mohanty L., Pulikkot S., Joshi P.G. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells. Cytotherapy 2011, 13:918-932.
65. Deierborg T., Soulet D., Roybon L., Hall V., Brundin P. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol. 2008, 85:407-432.
66. Delcroix G.J., Garbayo E., Sindji L., Thomas O., Vanpouille-Box C., Schiller P.C., Montero-Menei C.N. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats. Biomaterials 2011, 32:1560-1573.
67. Deng W., Obrocka M., Fischer I., Prockop D.J. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Commun. 2001, 282:148-152.
68. Deng J., Petersen B.E., Steindler D.A., Jorgensen M.L., Laywell E.D. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006, 24:1054-1064.
69. Deng J., Zou Z.M., Zhou T.L., Su Y.P., Ai G.P., Wang J.P., Xu H., Dong S.W. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol. Sci. 2011, 32:641-651.
70. Depino A.M., Earl C., Kaczmarczyk E., Ferrari C., Besedovsky H., del Rey A., Pitossi F.J., Oertel W.H. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur. J. Neurosci. 2003, 18:2731-2742.
71. Dezawa M. Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells. Cell. Mol. Life Sci. 2006, 63:2764-2772.
72. Dezawa M., Kanno H., Hoshino M., Cho H., Matsumoto N., Itokazu Y., Tajima N., Yamada H., Sawada H., Ishikawa H., Mimura T., Kitada M., Suzuki Y., Ide C. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 2004, 113:1701-1710.
73. Duinsbergen D., Salvatori D., Eriksson M., Mikkers H. Tumors originating from induced pluripotent stem cells and methods for their prevention. Ann. N. Y. Acad. Sci. 2009, 1176:197-204.
74. Dyson S.C., Barker R.A. Cell-based therapies for Parkinson's disease. Expert. Rev. Neurother. 2011, 11:831-844.
75. Eaves C.J., Cashman J.D., Sutherland H.J., Otsuka T., Humphries R.K., Hogge D.E., Lansdorp P.L., Eaves A.C. Molecular analysis of primitive hematopoietic cell proliferation control mechanisms. Ann. N. Y. Acad. Sci. 1991, 628:298-306.
76. Eberling J.L., Jagust W.J., Christine C.W., Starr P., Larson P., Bankiewicz K.S., Aminoff M.J. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 2008, 70:1980-1983.
77. Eberling J.L., Kells A.P., Pivirotto P., Beyer J., Bringas J., Federoff H.J., Forsayeth J., Bankiewicz K.S. Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys. Hum. Gene Ther. 2009, 20:511-518.
78. Ebert A.D., Beres A.J., Barber A.E., Svendsen C.N. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp. Neurol. 2008, 209:213-223.
79. Emborg M.E., Ebert A.D., Moirano J., Peng S., Suzuki M., Capowski E., Joers V., Roitberg B.Z., Aebischer P., Svendsen C.N. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant. 2008, 17:383-395.
80. Engele J., Bohn M.C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 1991, 11:3070-3078.
81. Ferrari G., Minozzi M.C., Toffano G., Leon A., Skaper S.D. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 1989, 133:140-147.
82. Fibbe W.E., Nauta A.J., Roelofs H. Modulation of immune responses by mesenchymal stem cells. Ann. N. Y. Acad. Sci. 2007, 1106:272-278.
83. Fox L.E., Shen J., Ma K., Liu Q., Shi G., Pappas G.D., Qu T., Cheng J. Membrane properties of neuron-like cells generated from adult human bone-marrow-derived mesenchymal stem cells. Stem Cells Dev. 2010, 19:1831-1841.
84. Friedenstein A.J., Piatetzky S., Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 1966, 16:381-390.
85. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
86. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970, 3:393-403.
87. Frim D.M., Uhler T.A., Galpern W.R., Beal M.F., Breakefield X.O., Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5104-5108.
88. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism. Stem Cells 2006, 24:115-124.
89. Fu L., Zhu L., Huang Y., Lee T.D., Forman S.J., Shih C.C. Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. Stem Cells Dev. 2008, 17:1109-1121.
90. Galindo L.T., Filippo T.R., Semedo P., Ariza C.B., Moreira C.M., Camara N.O., Porcionatto M.A. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol. Res. Int. 2011, 2011:564089.
91. Galpern W.R., Frim D.M., Tatter S.B., Altar C.A., Beal M.F., Isacson O. Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+rat model of substantia nigra degeneration. Cell Transplant. 1996, 5:225-232.
92. Ganz J., Lev N., Melamed E., Offen D. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?. Expert. Rev. Neurother. 2011, 11:1325-1339.
93. Gao H.M., Hong J.S., Zhang W., Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 2002, 22:782-790.
94. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380:252-255.
95. Gasmi M., Herzog C.D., Brandon E.P., Cunningham J.J., Ramirez G.A., Ketchum E.T., Bartus R.T. Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease. Mol. Ther. 2007, 15:62-68.
96. Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Mantegazza R., Frassoni F., Mancardi G., Pedotti R., Uccelli A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 2007, 61:219-227.
97. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 2003, 9:589-595.
98. Glavaski-Joksimovic A., Virag T., Chang Q.A., West N.C., Mangatu T.A., McGrogan M.P., Dugich-Djordjevic M., Bohn M.C. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Cell Transplant. 2009, 18:801-814.
99. Glavaski-Joksimovic A., Virag T., Mangatu T.A., McGrogan M., Wang X.S., Bohn M.C. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J. Neurosci. Res. 2010, 88:2669-2681.
100. Grandoso L., Ponce S., Manuel I., Arrue A., Ruiz-Ortega J.A., Ulibarri I., Orive G., Hernandez R.M., Rodriguez A., Rodriguez-Puertas R., Zumarraga M., Linazasoro G., Pedraz J.L., Ugedo L. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int. J. Pharm. 2007, 343:69-78.
101. Guo L., Yin F., Meng H.Q., Ling L., Hu-He T.N., Li P., Zhang C.X., Yu S., Duan D.S., Fan H.X. Differentiation of mesenchymal stem cells into dopaminergic neuron-like cells in vitro. Biomed. Environ. Sci. 2005, 18:36-42.
102. Hagg T., Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:6315-6319.
103. Hass R., Kasper C., Bohm S., Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 2011, 9:12.
104. Hayase M., Kitada M., Wakao S., Itokazu Y., Nozaki K., Hashimoto N., Takagi Y., Dezawa M. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J. Cereb. Blood Flow Metab. 2009, 29:1409-1420.
105. Hellmann M.A., Panet H., Barhum Y., Melamed E., Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci. Lett. 2006, 395:124-128.
106. Hermann A., Gastl R., Liebau S., Popa M.O., Fiedler J., Boehm B.O., Maisel M., Lerche H., Schwarz J., Brenner R., Storch A. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J. Cell Sci. 2004, 117:4411-4422.
107. Herzog C.D., Dass B., Holden J.E., Stansell J., Gasmi M., Tuszynski M.H., Bartus R.T., Kordower J.H. Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys. Mov. Disord. 2007, 22:1124-1132.
108. Ho A., Blum M. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice. Exp. Neurol. 1997, 148:348-359.
109. Hodgkinson C.P., Gomez J.A., Mirotsou M., Dzau V.J. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum. Gene Ther. 2010, 21:1513-1526.
110. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 1994, 182:107-111.
111. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A.M., Silberstein L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006, 24:1030-1041.
112. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., Deans R.J., Krause D.S., Keating A. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
113. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., Hirsch E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 1999, 19:3440-3447.
114. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991, 350:230-232.
115. Jang S., Cho H.H., Cho Y.B., Park J.S., Jeong H.S. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol 2010, 11:25.
116. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
117. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
118. Jiang Y., Henderson D., Blackstad M., Chen A., Miller R.F., Verfaillie C.M. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(Suppl. 1):11854-11860.
119. Jiang J., Lv Z., Gu Y., Li J., Xu L., Xu W., Lu J., Xu J. Adult rat mesenchymal stem cells differentiate into neuronal-like phenotype and express a variety of neuro-regulatory molecules in vitro. Neurosci. Res. 2010, 66:46-52.
120. Jin G.Z., Cho S.J., Choi E.G., Lee Y.S., Yu X.F., Choi K.S., Yee S.T., Jeon J.T., Kim M.O., Kong I.K. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Cell Biol. Int. 2008, 32:1433-1438.
121. Joannides A., Gaughwin P., Scott M., Watt S., Compston A., Chandran S. Postnatal astrocytes promote neural induction from adult human bone marrow-derived stem cells. J Hematother. Stem Cell Res. 2003, 12:681-688.
122. Johnston L.C., Eberling J., Pivirotto P., Hadaczek P., Federoff H.J., Forsayeth J. Clinically relevant effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Hum. Gene Ther. 2009, 20:497-510.
123. Kaigler D., Krebsbach P.H., Polverini P.J., Mooney D.J. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng. 2003, 9:95-103.
124. Kan I., Ben-Zur T., Barhum Y., Levy Y.S., Burstein A., Charlow T., Bulvik S., Melamed E., Offen D. Dopaminergic differentiation of human mesenchymal stem cells - utilization of bioassay for tyrosine hydroxylase expression. Neurosci. Lett. 2007, 419:28-33.
125. Kan I., Melamed E., Offen D. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Handb. Exp. Pharmacol. 2007, 219-242.
126. Kan I., Barhum Y., Melamed E., Offen D. Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev. 2011, 7:404-412.
127. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 1995, 672:104-111.
128. Kells A.P., Eberling J., Su X., Pivirotto P., Bringas J., Hadaczek P., Narrow W.C., Bowers W.J., Federoff H.J., Forsayeth J., Bankiewicz K.S. Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. J. Neurosci. 2010, 30:9567-9577.
129. Khoo M.L., Tao H., Meedeniya A.C., Mackay-Sim A., Ma D.D. Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents. PLoS One 2011, 6:e19025.
130. Kim B.J., Seo J.H., Bubien J.K., Oh Y.S. Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro. Neuroreport 2002, 13:1185-1188.
131. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sanchez-Pernaute R., Bankiewicz K., McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418:50-56.
132. Kim Y.J., Park H.J., Lee G., Bang O.Y., Ahn Y.H., Joe E., Kim H.O., Lee P.H. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009, 57:13-23.
133. Kim H.J., Lee J.H., Kim S.H. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J. Neurotrauma 2010, 27:131-138.
134. Kim J., Su S.C., Wang H., Cheng A.W., Cassady J.P., Lodato M.A., Lengner C.J., Chung C.Y., Dawlaty M.M., Tsai L.H., Jaenisch R. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 2011, 9:413-419.
135. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 2004, 94:678-685.
136. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S., Epstein S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
137. Kitamura Y., Itano Y., Kubo T., Nomura Y. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J. Neuroimmunol. 1994, 50:221-224.
138. Kohyama J., Abe H., Shimazaki T., Koizumi A., Nakashima K., Gojo S., Taga T., Okano H., Hata J., Umezawa A. Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 2001, 68:235-244.
139. Kooreman N.G., Wu J.C. Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J. R. Soc. Interface 2010, 7(Suppl. 6):S753-S763.
140. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10711-10716.
141. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290:767-773.
142. Kordower J.H., Herzog C.D., Dass B., Bakay R.A., Stansell J., Gasmi M., Bartus R.T. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Ann. Neurol. 2006, 60:706-715.
143. Kozlowski D.A., Connor B., Tillerson J.L., Schallert T., Bohn M.C. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Exp. Neurol. 2000, 166:1-15.
144. Kramer B.C., Woodbury D., Black I.B. Adult rat bone marrow stromal cells express genes associated with dopamine neurons. Biochem. Biophys. Res. Commun. 2006, 343:1045-1052.
145. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., Yang L., Beal M.F., Surmeier D.J., Kordower J.H., Tabar V., Studer L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
146. Labouyrie E., Dubus P., Groppi A., Mahon F.X., Ferrer J., Parrens M., Reiffers J., de Mascarel A., Merlio J.P. Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol. 1999, 154:405-415.
147. Lai Y., Sun Y., Skinner C.M., Son E.L., Lu Z., Tuan R.S., Jilka R.L., Ling J., Chen X.D. Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev. 2010, 19:1095-1107.
148. Lang A.E., Gill S., Patel N.K., Lozano A., Nutt J.G., Penn R., Brooks D.J., Hotton G., Moro E., Heywood P., Brodsky M.A., Burchiel K., Kelly P., Dalvi A., Scott B., Stacy M., Turner D., Wooten V.G., Elias W.J., Laws E.R., Dhawan V., Stoessl A.J., Matcham J., Coffey R.J., Traub M. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 2006, 59:459-466.
149. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 1999, 46:598-605.
150. Lattanzi W., Geloso M.C., Saulnier N., Giannetti S., Puglisi M.A., Corvino V., Gasbarrini A., Michetti F. Neurotrophic features of human adipose tissue-derived stromal cells: in vitro and in vivo studies. J. Biomed. Biotechnol. 2011, 2011:468705.
151. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., Semprun-Prieto L., Delafontaine P., Prockop D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
152. Li Y., Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 2009, 456:120-123.
153. Li Y., Chen J., Wang L., Lu M., Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001, 56:1666-1672.
154. Li Y., Chen J., Wang L., Zhang L., Lu M., Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci. Lett. 2001, 316:67-70.
155. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523.
156. Li J., Zhu H., Liu Y., Li Q., Lu S., Feng M., Xu Y., Huang L., Ma C., An Y., Zhao R.C., Wang R., Qin C. Human mesenchymal stem cell transplantation protects against cerebral ischemic injury and upregulates interleukin-10 expression in Macaca fascicularis. Brain Res. 2010, 1334:65-72.
157. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
158. Lindvall O., Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol. Sci. 2009, 30:260-267.
159. Lindvall O., Wahlberg L.U. Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?. Exp. Neurol. 2008, 209:82-88.
160. Ling G.S., Ecklund J.M. Traumatic brain injury in modern war. Curr. Opin. Anaesthesiol. 2011, 24:124-130.
161. Ling G., Bandak F., Armonda R., Grant G., Ecklund J. Explosive blast neurotrauma. J. Neurotrauma 2009, 26:815-825.
162. Liu W.-G., Lu G.-Q., Li B., Chen S.-D. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:77-88.
163. Liu X., Li F., Stubblefield E.A., Blanchard B., Richards T.L., Larson G.A., He Y., Huang Q., Tan A.C., Zhang D., Benke T.A., Sladek J.R., Zahniser N.R., Li C.Y. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012, 22:321-332.
164. Long X., Olszewski M., Huang W., Kletzel M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev. 2005, 14:65-69.
165. Lopez-Iglesias P., Blazquez-Martinez A., Fernandez-Delgado J., Regadera J., Nistal M., Miguel M.P. Short and long term fate of human AMSC subcutaneously injected in mice. World J. Stem Cells 2011, 3:53-62.
166. Lu P., Blesch A., Tuszynski M.H. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact?. J. Neurosci. Res. 2004, 77:174-191.
167. Lu L., Zhao C., Liu Y., Sun X., Duan C., Ji M., Zhao H., Xu Q., Yang H. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res. Protoc. 2005, 15:46-51.
168. Lu J., Moochhala S., Moore X.L., Ng K.C., Tan M.H., Lee L.K., He B., Wong M.C., Ling E.A. Adult bone marrow cells differentiate into neural phenotypes and improve functional recovery in rats following traumatic brain injury. Neurosci. Lett. 2006, 398:12-17.
169. Lu S., Lu C., Han Q., Li J., Du Z., Liao L., Zhao R.C. Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Toxicology 2011, 279:189-195.
170. Ma L., Liu Y., Zhang S.C. Directed differentiation of dopamine neurons from human pluripotent stem cells. Methods Mol. Biol. 2011, 767:411-418.
171. Magal E., Burnham P., Varon S., Louis J.C. Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra. Neuroscience 1993, 52:867-881.
172. Mahmood A., Lu D., Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 2004, 55:1185-1193.
173. Mareschi K., Novara M., Rustichelli D., Ferrero I., Guido D., Carbone E., Medico E., Madon E., Vercelli A., Fagioli F. Neural differentiation of human mesenchymal stem cells: evidence for expression of neural markers and eag K+channel types. Exp. Hematol. 2006, 34:1563-1572.
174. Marks W.J., Ostrem J.L., Verhagen L., Starr P.A., Larson P.S., Bakay R.A., Taylor R., Cahn-Weiner D.A., Stoessl A.J., Olanow C.W., Bartus R.T. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 2008, 7:400-408.
175. Marks W.J., Bartus R.T., Siffert J., Davis C.S., Lozano A., Boulis N., Vitek J., Stacy M., Turner D., Verhagen L., Bakay R., Watts R., Guthrie B., Jankovic J., Simpson R., Tagliati M., Alterman R., Stern M., Baltuch G., Starr P.A., Larson P.S., Ostrem J.L., Nutt J., Kieburtz K., Kordower J.H., Olanow C.W. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010, 9:1164-1172.
176. Mathieu P., Roca V., Gamba C., Del Pozo A., Pitossi F. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson's disease. J. Neuroimmunol. 2012, 246:43-50.
177. Matsuura K., Kabuto H., Makino H., Ogawa N. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain. Brain Res. 1996, 733:101-104.
178. Matsuura K., Kabuto H., Makino H., Ogawa N. Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice. Neurosci. Lett. 1997, 230:191-194.
179. Matsuura K., Makino H., Ogawa N. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 1997, 146:526-535.
180. Matysiak M., Orlowski W., Fortak-Michalska M., Jurewicz A., Selmaj K. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J. Neuroimmunol. 2011, 233:106-111.
181. McCoy M.K., Martinez T.N., Ruhn K.A., Wrage P.C., Keefer E.W., Botterman B.R., Tansey K.E., Tansey M.G. Autologous transplants of adipose-derived adult stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. Exp. Neurol. 2008, 210:14-29.
182. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
183. McLay R.N., Freeman S.M., Zadina J.E. Administration of FGF-1 through transfected cells alleviates MPTP toxicity in mice. Neurotox. Res. 2001, 3:249-253.
184. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., Crain B. Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1364-1369.
185. Mezey E., Mayer B., Nemeth K. Unexpected roles for bone marrow stromal cells (or MSCs): a real promise for cellular, but not replacement, therapy. Oral Dis. 2010, 16:129-135.
186. Mimura T., Dezawa M., Kanno H., Yamamoto I. Behavioral and histological evaluation of a focal cerebral infarction rat model transplanted with neurons induced from bone marrow stromal cells. J. Neuropathol. Exp. Neurol. 2005, 64:1108-1117.
187. Mittermeyer G., Christine C.W., Rosenbluth K.H., Baker S.L., Starr P., Larson P., Kaplan P.L., Forsayeth J., Aminoff M.J., Bankiewicz K.S. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum. Gene Ther. 2012, 23:377-381.
188. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 1994, 180:147-150.
189. Moloney T.C., Rooney G.E., Barry F.P., Howard L., Dowd E. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the parkinsonian rat brain. Brain Res. 2010, 1359:33-43.
190. Montzka K., Lassonczyk N., Tschoke B., Neuss S., Fuhrmann T., Franzen R., Smeets R., Brook G.A., Woltje M. Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci. 2009, 10:16.
191. Morizane A., Takahashi J. A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease. Brain Nerve 2012, 64:29-37.
192. Munoz J.R., Stoutenger B.R., Robinson A.P., Spees J.L., Prockop D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18171-18176.
193. Nagai A., Kim W.K., Lee H.J., Jeong H.S., Kim K.S., Hong S.H., Park I.H., Kim S.U. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS One 2007, 2:e1272.
194. Nagatsu T., Mogi M., Ichinose H., Togari A. Cytokines in Parkinson's disease. J. Neural Transm. Suppl. 2000, 143-151.
195. Natsume A., Mata M., Goss J., Huang S., Wolfe D., Oligino T., Glorioso J., Fink D.J. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp. Neurol. 2001, 169:231-238.
196. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
197. Nemeth K., Leelahavanichkul A., Yuen P.S., Mayer B., Parmelee A., Doi K., Robey P.G., Leelahavanichkul K., Koller B.H., Brown J.M., Hu X., Jelinek I., Star R.A., Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 2009, 15:42-49.
198. Neuhuber B., Gallo G., Howard L., Kostura L., Mackay A., Fischer I. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J. Neurosci. Res. 2004, 77:192-204.
199. Nishino H., Hida H., Takei N., Kumazaki M., Nakajima K., Baba H. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum. Exp. Neurol. 2000, 164:209-214.
200. Nutt J.G., Burchiel K.J., Comella C.L., Jankovic J., Lang A.E., Laws E.R., Lozano A.M., Penn R.D., Simpson R.K., Stacy M., Wooten G.F. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 2003, 60:69-73.
201. Offen D., Barhum Y., Levy Y.S., Burshtein A., Panet H., Cherlow T., Melamed E. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. J. Neural Transm. Suppl. 2007, 133-143.
202. Oh J.Y., Lee R.H., Yu J.M., Ko J.H., Lee H.J., Ko A.Y., Roddy G.W., Prockop D.J. Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol. Ther. 2012, 20:2143-2152.
203. Oiwa Y., Yoshimura R., Nakai K., Itakura T. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. Brain Res. 2002, 947:271-283.
204. Omori Y., Honmou O., Harada K., Suzuki J., Houkin K., Kocsis J.D. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res. 2008, 1236:30-38.
205. Onda T., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood Flow Metab. 2008, 28:329-340.
206. Ortiz L.A., Dutreil M., Fattman C., Pandey A.C., Torres G., Go K., Phinney D.G. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11002-11007.
207. Ouchi Y., Yoshikawa E., Sekine Y., Futatsubashi M., Kanno T., Ogusu T., Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 2005, 57:168-175.
208. Pacary E., Legros H., Valable S., Duchatelle P., Lecocq M., Petit E., Nicole O., Bernaudin M. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J. Cell Sci. 2006, 119:2667-2678.
209. Palmer T.D., Willhoite A.R., Gage F.H. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 2000, 425:479-494.
210. Parish C.L., Arenas E. Stem-cell-based strategies for the treatment of Parkinson's disease. Neurodegener. Dis. 2007, 4:339-347.
211. Park K.W., Eglitis M.A., Mouradian M.M. Protection of nigral neurons by GDNF-engineered marrow cell transplantation. Neurosci. Res. 2001, 40:315-323.
212. Park H.J., Lee P.H., Bang O.Y., Lee G., Ahn Y.H. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J. Neurochem. 2008, 107:141-151.
213. Park H.J., Shin J.Y., Lee B.R., Kim H.O., Lee P.H. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model. Cell Transplant. 2012, 21:1629-1640.
214. Park H.W., Cho J.S., Park C.K., Jung S.J., Park C.H., Lee S.J., Oh S.B., Park Y.S., Chang M.S. Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells. PLoS One 2012, 7:e35244.
215. Parr A.M., Tator C.H., Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007, 40:609-619.
216. Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol. 2005, 57:298-302.
217. Pavlichenko N., Sokolova I., Vijde S., Shvedova E., Alexandrov G., Krouglyakov P., Fedotova O., Gilerovich E.G., Polyntsev D.G., Otellin V.A. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res. 2008, 1233:203-213.
218. Pavon-Fuentes N., Blanco-Lezcano L., Martinez-Martin L., Castillo-Diaz L., de la Cuetara-Bernal K., Garcia-Miniet R., Lorigados-Pedre L., Coro-Grave de Peralta Y., Garcia-Varona A.Y., Rosillo-Marti J.C., Macias-Gonzalez R. Stromal cell transplant in the 6-OHDA lesion model. Rev. Neurol. 2004, 39:326-334.
219. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12543-12548.
220. Pfisterer U., Kirkeby A., Torper O., Wood J., Nelander J., Dufour A., Bjorklund A., Lindvall O., Jakobsson J., Parmar M. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10343-10348.
221. Pisati F., Bossolasco P., Meregalli M., Cova L., Belicchi M., Gavina M., Marchesi C., Calzarossa C., Soligo D., Lambertenghi-Deliliers G., Bresolin N., Silani V., Torrente Y., Polli E. Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant. 2007, 16:41-55.
222. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
223. Preston M.R., el Haj A.J., Publicover S.J. Expression of voltage-operated Ca2+ channels in rat bone marrow stromal cells in vitro. Bone 1996, 19:101-106.
224. Prockop D.J., Oh J.Y. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol. Ther. 2012, 20:14-20.
225. Reiser J., Zhang X.Y., Hemenway C.S., Mondal D., Pradhan L., La Russa V.F. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert. Opin. Biol. Ther. 2005, 5:1571-1584.
226. Rhee Y.H., Ko J.Y., Chang M.Y., Yi S.H., Kim D., Kim C.H., Shim J.W., Jo A.Y., Kim B.W., Lee H., Lee S.H., Suh W., Park C.H., Koh H.C., Lee Y.S., Lanza R., Kim K.S., Lee S.H. Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J. Clin. Invest. 2011, 121:2326-2335.
227. Rivera F.J., Sierralta W.D., Minguell J.J., Aigner L. Adult hippocampus derived soluble factors induce a neuronal-like phenotype in mesenchymal stem cells. Neurosci. Lett. 2006, 406:49-54.
228. Robinson A.P., Foraker J.E., Ylostalo J., Prockop D.J. Human stem/progenitor cells from bone marrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor beta and Notch signaling. Stem Cells Dev. 2011, 20:289-300.
229. Roddy G.W., Oh J.Y., Lee R.H., Bartosh T.J., Ylostalo J., Coble K., Rosa R.H., Prockop D.J. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 2011, 29:1572-1579.
230. Rosenblad C., Kirik D., Devaux B., Moffat B., Phillips H.S., Bjorklund A. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur. J. Neurosci. 1999, 11:1554-1566.
231. Roy N.S., Cleren C., Singh S.K., Yang L., Beal M.F., Goldman S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 2006, 12:1259-1268.
232. Sadan O., Bahat-Stromza M., Barhum Y., Levy Y.S., Pisnevsky A., Peretz H., Bar Ilan A., Bulvik S., Shemesh N., Krepel D., Cohen Y., Melamed E., Offen D. Protective effects of neurotrophic factors secreting cells in a 6OHDA rat model of Parkinson disease. Stem Cells Dev. 2009, 18:1179-1190.
233. Sakurada K., Ohshima-Sakurada M., Palmer T.D., Gage F.H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 1999, 126:4017-4026.
234. Sanchez-Pernaute R., Studer L., Ferrari D., Perrier A., Lee H., Vinuela A., Isacson O. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells 2005, 23:914-922.
235. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., Hazzi C., Stedeford T., Willing A., Freeman T.B., Saporta S., Janssen W., Patel N., Cooper D.R., Sanberg P.R. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 2000, 164:247-256.
236. Sauer H., Fischer W., Nikkhah G., Wiegand S.J., Brundin P., Lindsay R.M., Bjorklund A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 1993, 626:37-44.
237. Schaar D.G., Sieber B.A., Dreyfus C.F., Black I.B. Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 1993, 124:368-371.
238. Schumacher J.M., Short M.P., Hyman B.T., Breakefield X.O., Isacson O. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 1991, 45:561-570.
239. Schwarz E.J., Alexander G.M., Prockop D.J., Azizi S.A. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther. 1999, 10:2539-2549.
240. Shi D., Chen G., Lv L., Li L., Wei D., Gu P., Gao J., Miao Y., Hu W. The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model. Neurol. Sci. 2011, 32:41-51.
241. Shintani A., Nakao N., Kakishita K., Itakura T. Protection of dopamine neurons by bone marrow stromal cells. Brain Res. 2007, 1186:48-55.
242. Slevin J.T., Gerhardt G.A., Smith C.D., Gash D.M., Kryscio R., Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 2005, 102:216-222.
243. Somoza R., Juri C., Baes M., Wyneken U., Rubio F.J. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. Biol. Blood Marrow Transplant. 2010, 16:1530-1540.
244. Song H., Stevens C.F., Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002, 417:39-44.
245. Spees J.L., Olson S.D., Ylostalo J., Lynch P.J., Smith J., Perry A., Peister A., Wang M.Y., Prockop D.J. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2397-2402.
246. Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 2007, 69:1-9.
247. Sueblinvong V., Loi R., Eisenhauer P.L., Bernstein I.M., Suratt B.T., Spees J.L., Weiss D.J. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am. J. Respir. Crit. Care Med. 2008, 177:701-711.
248. Suzuki H., Taguchi T., Tanaka H., Kataoka H., Li Z., Muramatsu K., Gondo T., Kawai S. Neurospheres induced from bone marrow stromal cells are multipotent for differentiation into neuron, astrocyte, and oligodendrocyte phenotypes. Biochem. Biophys. Res. Commun. 2004, 322:918-922.
249. Tansey M.G., Goldberg M.S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 2010, 37:510-518.
250. Tao H., Rao R., Ma D.D. Cytokine-induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition. Dev. Growth Differ. 2005, 47:423-433.
251. Tate C.C., Fonck C., McGrogan M., Case C.C. Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia. Cell Transplant. 2010, 19:973-984.
252. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson-Lewis V., Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5473-5478.
253. Teng H., Zhang Z.G., Wang L., Zhang R.L., Zhang L., Morris D., Gregg S.R., Wu Z., Jiang A., Lu M., Zlokovic B.V., Chopp M. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J. Cereb. Blood Flow Metab. 2008, 28:764-771.
254. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416:542-545.
255. Tfilin M., Sudai E., Merenlender A., Gispan I., Yadid G., Turgeman G. Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol. Psychiatry 2010, 15:1164-1175.
256. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995, 373:335-339.
257. Tondreau T., Lagneaux L., Dejeneffe M., Massy M., Mortier C., Delforge A., Bron D. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 2004, 72:319-326.
258. Tondreau T., Dejeneffe M., Meuleman N., Stamatopoulos B., Delforge A., Martiat P., Bron D., Lagneaux L. Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC Genomics 2008, 9:166.
259. Trzaska K.A., Kuzhikandathil E.V., Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 2007, 25:2797-2808.
260. Trzaska K.A., King C.C., Li K.Y., Kuzhikandathil E.V., Nowycky M.C., Ye J.H., Rameshwar P. Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J. Neurochem. 2009, 110:1058-1069.
261. Vassilopoulos G., Wang P.R., Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422:901-904.
262. Venkataramana N.K., Kumar S.K., Balaraju S., Radhakrishnan R.C., Bansal A., Dixit A., Rao D.K., Das M., Jan M., Gupta P.K., Totey S.M. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 2010, 155:62-70.
263. Waddington R.J., Youde S.J., Lee C.P., Sloan A.J. Isolation of distinct progenitor stem cell populations from dental pulp. Cells Tissues Organs 2009, 189:268-274.
264. Wahner A.D., Bronstein J.M., Bordelon Y.M., Ritz B. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 2007, 69:1836-1842.
265. Wakabayashi K., Nagai A., Sheikh A.M., Shiota Y., Narantuya D., Watanabe T., Masuda J., Kobayashi S., Kim S.U., Yamaguchi S. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J. Neurosci. Res. 2010, 88:1017-1025.
266. Wakeman D.R., Dodiya H.B., Kordower J.H. Cell transplantation and gene therapy in Parkinson's disease. Mt. Sinai J. Med. 2011, 78:126-158.
267. Wang J., Bankiewicz K.S., Plunkett R.J., Oldfield E.H. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J. Neurosurg. 1994, 80:484-490.
268. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Olson S., Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422:897-901.
269. Wang Y., Deng Z., Lai X., Tu W. Differentiation of human bone marrow stromal cells into neural-like cells induced by sodium ferulate in vitro. Cell. Mol. Immunol. 2005, 2:225-229.
270. Wang T.H., Feng Z.T., Wei P., Li H., Shi Z.J., Li L.Y. Effects of pcDNA3-beta-NGF gene-modified BMSC on the rat model of Parkinson's disease. J. Mol. Neurosci. 2008, 35:161-169.
271. Wang F., Yasuhara T., Shingo T., Kameda M., Tajiri N., Yuan W.J., Kondo A., Kadota T., Baba T., Tayra J.T., Kikuchi Y., Miyoshi Y., Date I. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci. 2010, 11:52.
272. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., Luo Y., Rao M.S., Velagaleti G., Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
273. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5856-5861.
274. Wilby M.J., Sinclair S.R., Muir E.M., Zietlow R., Adcock K.H., Horellou P., Rogers J.H., Dunnett S.B., Fawcett J.W. A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J. Neurosci. 1999, 19:2301-2312.
275. Wilkins A., Kemp K., Ginty M., Hares K., Mallam E., Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. 2009, 3:63-70.
276. Wislet-Gendebien S., Leprince P., Moonen G., Rogister B. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J. Cell Sci. 2003, 116:3295-3302.
277. Wislet-Gendebien S., Hans G., Leprince P., Rigo J.M., Moonen G., Rogister B. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 2005, 23:392-402.
278. Wislet-Gendebien S., Wautier F., Leprince P., Rogister B. Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res. Bull. 2005, 68:95-102.
279. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 2000, 61:364-370.
280. Woodbury D., Reynolds K., Black I.B. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J. Neurosci. Res. 2002, 69:908-917.
281. Wu J., Yu W., Chen Y., Su Y., Ding Z., Ren H., Jiang Y., Wang J. Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model. Neurochem. Res. 2010, 35:495-502.
282. Xiong Y., Qu C., Mahmood A., Liu Z., Ning R., Li Y., Kaplan D.L., Schallert T., Chopp M. Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats. Brain Res. 2009, 1263:183-191.
283. Xiong N., Cao X., Zhang Z., Huang J., Chen C., Zhang Z., Jia M., Xiong J., Liang Z., Sun S., Lin Z., Wang T. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol. Blood Marrow Transplant. 2010, 16:1519-1529.
284. Xiong N., Zhang Z., Huang J., Chen C., Zhang Z., Jia M., Xiong J., Liu X., Wang F., Cao X., Liang Z., Sun S., Lin Z., Wang T. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 2011, 18:394-402.
285. Yang M., Donaldson A.E., Marshall C.E., Shen J., Iacovitti L. Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo. Cell Transplant. 2004, 13:535-547.
286. Yasuhara T., Shingo T., Kobayashi K., Takeuchi A., Yano A., Muraoka K., Matsui T., Miyoshi Y., Hamada H., Date I. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur. J. Neurosci. 2004, 19:1494-1504.
287. Yasuhara T., Shingo T., Muraoka K., Kobayashi K., Takeuchi A., Yano A., Wenji Y., Kameda M., Matsui T., Miyoshi Y., Date I. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J. Neurosurg. 2005, 102:80-89.
288. Yasuhara T., Matsukawa N., Hara K., Yu G., Xu L., Maki M., Kim S.U., Borlongan C.V. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J. Neurosci. 2006, 26:12497-12511.
289. Ye M., Wang X.J., Zhang Y.H., Lu G.Q., Liang L., Xu J.Y., Chen S.D. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease. Brain Res. 2007, 1142:206-216.
290. Ye M., Wang X.J., Zhang Y.H., Lu G.Q., Liang L., Xu J.Y., Sheng-Di C. Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:44-49.
291. Yoshimoto Y., Lin Q., Collier T.J., Frim D.M., Breakefield X.O., Bohn M.C. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 1995, 691:25-36.
292. Yue W.M., Liu W., Bi Y.W., He X.P., Sun W.Y., Pang X.Y., Gu X.H., Wang X.P. Mesenchymal stem cells differentiate into an endothelial phenotype, reduce neointimal formation, and enhance endothelial function in a rat vein grafting model. Stem Cells Dev. 2008, 17:785-793.
293. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755-1761.
294. Zeng R., Wang L.W., Hu Z.B., Guo W.T., Wei J.S., Lin H., Sun X., Chen L.X., Yang L.J. Differentiation of human bone marrow mesenchymal stem cells into neuron-like cells in vitro. Spine (Phila Pa 1976) 2011, 36:997-1005.
295. Zhang Z., Alexanian A.R. The neural plasticity of early-passage human bone marrow-derived mesenchymal stem cells and their modulation with chromatin-modifying agents. J. Tissue Eng. Regen. Med. 2012, 10.1002/term.1535.
296. Zhang W., Wang X., Yang Y. Human GDNF cDNA-engineered SH-SY5Y cells' neurotrophic and protective effect on primary dopaminergic neurons of rat. Zhonghua yi xue za zhi 2001, 81:1384-1386.
297. Zhang Z., Wang X., Wang S. Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease. In Vitro Cell. Dev. Biol. Anim. 2008, 44:169-177.
298. Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 2002, 174:11-20.
299. Zhao L.X., Zhang J., Cao F., Meng L., Wang D.M., Li Y.H., Nan X., Jiao W.C., Zheng M., Xu X.H., Pei X.T. Modification of the brain-derived neurotrophic factor gene: a portal to transform mesenchymal stem cells into advantageous engineering cells for neuroregeneration and neuroprotection. Exp. Neurol. 2004, 190:396-406.